FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model

Transplant Proc. 2007 Mar;39(2):493-8. doi: 10.1016/j.transproceed.2007.01.021.

Abstract

Background: Ischemia-reperfusion-Injury (I/RI) is a common complication in transplant-, liver-, and heart surgery. The I/RI is mediated and aggravated by different types of leukocytes such as lymphocytes, monocytes, and neutrophil granulocytes, with consecutive enlargement of the expression of adhesion molecules. This study shows an organ-protective effect of an intraoperative FTY720 administration following warm liver ischemia (Pringle's maneuver).

Methods: Male c57BL6/J mice (n = 46, body weight [BW] 25 to 30 g) were used. Either FTY720 (1 mg/kg BW), steroids (5 mg/kg BW), or physiological saline solution was administered intraperitoneally. Liver-ischemia was applied for 30 minutes with subsequent follow-up for 48 hours. At termination, all surviving animals were sacrificed. The impact of the drugs administered on long-term survival, time of death, and development of blood T-lymphocyte concentration was determined. Follow-up of T-lymphocyte concentration in peripheral blood was examined throughout FACS-analysis.

Results: Following 30 minutes of ischemia, FTY720, but not steroid or vehicle treatment, showed a significant protective effect on long-term survival. FACS-analysis showed significant T-lymphocyte depletion in peripheral blood following FTY720 but not steroids or vehicle treatment.

Conclusion: The improved long-term survival following FTY720 application shown in this study might be due to a protective effect of FTY720 in prevention of I/RI. This might be mediated by the T-lymphocyte depletion shown in the FACS-analysis.

MeSH terms

  • Animals
  • Fingolimod Hydrochloride
  • Immunosuppressive Agents / therapeutic use*
  • Liver / blood supply
  • Liver / drug effects
  • Liver / immunology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Models, Animal
  • Propylene Glycols / therapeutic use*
  • Reperfusion Injury / mortality
  • Reperfusion Injury / prevention & control*
  • Sphingosine / analogs & derivatives*
  • Sphingosine / therapeutic use
  • Survival Analysis
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine